Welcome to our dedicated page for AlphaTON Capital news (Ticker: ATON), a resource for investors and traders seeking the latest updates and insights on AlphaTON Capital stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AlphaTON Capital's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AlphaTON Capital's position in the market.
AlphaTON Capital (Nasdaq: ATON) selected P2P.org as its first institutional staking partner for TON treasury operations on Nov 17, 2025. The agreement enables non-custodial staking of an initial 4 million locked TON tokens via BitGo custody to generate sustainable yields while maintaining AlphaTON's control of assets. P2P.org will provide validator infrastructure, monitoring, reporting, and automated reward distribution. The setup leverages P2P.org's reported zero slashing record and 99.9% uptime and marks the start of AlphaTON's planned expansion of TON staking as part of its treasury yield strategy.
AlphaTON Capital (Nasdaq: ATON) announced a strategic partnership with SingularityNET, CUDO Compute, and Vertical Data to accelerate Telegram's Cocoon AI by deploying a hydroelectric-powered GPU fleet in Sweden. The GPU infrastructure, financed through Vertical Data’s GPUFinancing.com, is designed to support decentralized, privacy-preserving AI that keeps user data encrypted and under user control.
The initial GPU deployment is expected to begin in Q4 2025, with plans to scale through 2026 based on Cocoon AI demand; financial terms remain subject to final definitive agreements.
AlphaTON (Nasdaq: ATON) and its oncology subsidiary Cyncado Therapeutics announced a non-binding Letter of Intent with Australia’s Asbestos and Dust Diseases Research Institute (ADDRI) to run an investigator-initiated trial of TT-4, a selective A2B receptor antagonist, in mesothelioma on Nov 12, 2025.
The ADDRI-sponsored study is planned to enroll approximately 50 patients, will be led by A/Prof Steven Kao and Dr Melvin Chin, and will run alongside Cyncado’s planned U.S. mesothelioma activities, subject to a definitive agreement and customary approvals. Cyncado will provide TT-4 and limited support. The trial targets second-line/after first-line settings where options remain limited.
AlphaTON Capital (Nasdaq: ATON) appointed William De’Ath as Chief Partnership Officer on November 11, 2025 to lead global partnerships, institutional adoption, M&A sourcing, and the rollout of the TON Mastercard. The TON Mastercard will be developed with partners Pago Pay and ALT5 Sigma. De’Ath brings 30+ years of commercial strategy experience across Fortune 500s, blockchain custody integrations (including Taurus SA for major banks), AI ventures, and a reported $28M ARR delivery at PETRONAS. His remit includes ecosystem expansion across DeFi, gaming, and mini-app infrastructure and coordinating commercial diligence for revenue-generating deals.
AlphaTON Capital (Nasdaq: ATON) and subsidiary Cyncado Therapeutics reported preclinical results showing that co‑administration of selective adenosine A2B antagonist TT-4 and A2A antagonist TT-10 with antigen-specific cancer vaccines produced strong antitumor effects in three mouse models.
The triple combination (TT-4 + TT-10 + vaccine) significantly suppressed tumor growth, improved survival, elicited intratumoral CD8+ T-cell responses, produced complete tumor regressions in several mice, and conferred resistance to tumor rechallenge. Data were presented at SITC on November 8, 2025. Clinical status: TT-10 is in Phase 1 dose escalation and TT-4 is IND-enabled and preparing for first‑patient dosing in Q1 2026.
AlphaTON Capital (Nasdaq: ATON) announced definitive terms to acquire Blockchain Wire, a press release distribution service for blockchain, crypto, and digital asset sectors. Blockchain Wire reports >100% CAGR since 2023, is profitable, and serves 4,000+ clients. AlphaTON plans to integrate Blockchain Wire into its ecosystem and launch the world's first verifiable newswire on The Open Network (TON), using cryptographic time-stamping and Telegram mini-apps to verify and trace press releases. The acquisition is expected to close in Q1 2026, subject to customary closing conditions, and Blockchain Wire will become a wholly owned subsidiary.
AlphaTON Capital (Nasdaq: ATON) announced that CEO Brittany Kaiser will speak on a high-profile panel at SALT London 2025, taking place November 5–8, 2025. The panel is titled “New Access Points: DeFi, Tokenization, and Digital Asset Treasuries (DATs)” and will be moderated by Camilla McFarland, Chief Growth Officer at The Ether Machine.
Panelists include Patrick Horsman (CIO, BNBX), Michael Healy (Co-founder, Unit Network), and Henry K. Elder (CEO, Satsuma Technology). The session will explore institutional access, tokenized assets, decentralized finance, and implications for capital markets and Web3 adoption, including references to the TON network.
AlphaTON Capital (Nasdaq: ATON) announced a joint venture with PagoPay, ALT5 Sigma (Nasdaq: ALTS) and World Liberty Financial to launch a TON Mastercard payment card program enabling native TON, USD1 and other crypto spending directly from digital wallets.
The program will offer physical and virtual cards for U.S. and international use, use ALT5 for crypto-to-fiat conversion, grant AlphaTON exclusive marketing/distribution rights, include an option for AlphaTON to acquire 100% operational control and contemplate PagoPay equity participation. Parties expect definitive agreements within 30 days and target initial card production about 90 days after Mastercard approval, subject to regulatory compliance.
AlphaTON Capital (Nasdaq: ATON) announced CEO Brittany Kaiser and senior leaders will participate in the TRUST Summit 2025 hosted by Hacken at Nasdaq MarketSite in New York on Nov. 3, 2025.
The invite-only forum gathers about 100 policymakers, institutional investors, and cybersecurity experts to discuss secure, scalable blockchain adoption, decentralized AI, and data-rights frameworks. The event is part of AlphaTON’s 2025 Global Tour, following Washington D.C. meetings and preceding stops in London, Lisbon, Abu Dhabi, Miami, and Davos.
AlphaTON said the summit aims to align trust, compliance, privacy, and security across regulators and institutions.
AlphaTON Capital (Nasdaq: ATON) is launching a global World Tour with an Investor Breakfast at the Nasdaq MarketSite in New York on November 3, 2025. Speakers include Brittany Kaiser (CEO), Enzo Villani (Chairman & CIO) and Michael Terpin (independent board member).
AlphaTON says it raised $71 million to accelerate a global strategy as the first TON Digital Asset Treasury (DAT) focused on M&A and ecosystem investments, with stated expansion into gaming, DeFi and broader Web3 accessibility via Telegram’s user base.
FAQ
What is the current stock price of AlphaTON Capital (ATON)?
What is the market cap of AlphaTON Capital (ATON)?
